Table 1.
Demographics, raw and change scores (Δ) with tests of between-treatment differences (fear-avoidance in-session exposure vs fear-avoidance) and partial correlations between change scores in the pooled patient sample.
| Pre Treatment | Booster Session | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| FA (n = 32) | FA-ISE (n = 37) | P | FA (n = 32) | FA-ISE (n = 37) | P | |||||
| Demographics | N | % | N | % | N | % | N | % | ||
| Gender (male) | 9 | 28% | 17 | 46% | 0.13 | |||||
| N | SD | N | SD | M | SD | M | SD | |||
| Age (years) | 43.3 | 9.9 | 43.9 | 9.7 | 0.83 | |||||
| Variables* | ||||||||||
| API | 3.9 | 1.7 | 3.8 | 1.6 | 0.88 | 2.8 | 1.8 | 3.7 | 2.2 | 0.09 |
| WSAS | 10.9 | 7.1 | 13.1 | 9.0 | 0.27 | 7.8 | 8.3 | 10.3 | 9.5 | 0.26 |
| PFS | 6.7 | 3.2 | 7.1 | 4.8 | 0.70 | 4.7 | 3.0 | 6.1 | 5.0 | 0.18 |
| BPS | 5.2 | 3.7 | 4.7 | 3.7 | 0.45 | 2.6 | 3.1 | 4.1 | 3.5 | 0.09 |
| FABQ | 28.4 | 14.8 | 29.3 | 16.6 | 0.82 | 18.6 | 15.8 | 25.2 | 17.9 | 0.12 |
| ASES | 52.2 | 25.9 | 52.1 | 30.6 | 0.99 | 71.7 | 23.6 | 64.1 | 27.6 | 0.23 |
| PCS | 15.5 | 10.3 | 14.3 | 8.7 | 0.58 | 9.9 | 9.2 | 12.1 | 10.1 | 0.36 |